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ABSTRACT
The Epstein-Barr virus (EBV) transforms B cells
by expressing latent proteins and the BHRF1 mi-
croRNA cluster. MiR-BHRF1–3, its most transform-
ing member, belongs to the recently identified group
of weakly expressed microRNAs. We show here that
miR-BHRF1–3 displays an unusually low propensity
to form a stem–loop structure, an effect potentiated
by miR-BHRF1–3’s proximity to the BHRF1 polyA
site. Cloning miR-BHRF1–2 or a cellular microRNA,
but not a ribozyme, 5′ of miR-BHRF1–3 markedly
enhanced its expression. However, a virus carrying
mutated miR-BHRF1–2 seed regions expressed miR-
BHRF1–3 at normal levels and was fully transform-
ing. Therefore, miR-BHRF1–2’s role during transfor-
mation is independent of its seed regions, revealing
a new microRNA function. Increasing the distance
between miR-BHRF1–2 and miR-BHRF1–3 in EBV en-
hanced miR-BHRF1–3’s expression but decreased its
transforming potential. Thus, the expression of some
microRNAs must be restricted to a narrow range, as
achieved by placing miR-BHRF1–3 under the control
of miR-BHRF1–2.
INTRODUCTION
MicroRNAs (miRNAs) are small regulatory RNAs that
serve crucial roles in a wide range of cellular processes such
as differentiation, immune and inflammatory signaling,
proliferation or apoptosis (1–4) and are commonly dereg-
ulated in cancer (5,6). MiRNAs are processed from pri-
mary transcripts that comprise a double-stranded miRNA
stem–loop that is targeted and cleaved in the nucleus by the
Microprocessor complex containing the RNase III enzyme
Drosha andDiGeorge syndrome critical region 8 (DGCR8)
(7,8). The cleavage liberates a pre-miRNA hairpin which is
exported by Exportin 5 (9) and further processed by Dicer
in the cytoplasm to yield a 19–22nt long mature miRNA
that is incorporated into the RNA-induced silencing com-
plex (RISC) with an Argonaute protein (10,11). The nu-
cleotides 2–8 of a mature miRNA are termed the seed re-
gion and are crucial for recognition of most target RNAs,
while the remaining sequence has only partial complemen-
tarity (12). This enables miRNAs to interact with hundreds
of potential target genes (13) andmakes them ideal tools for
manipulation of host cell processes by viruses.
The first viral miRNAs were identified in the Epstein-
Barr virus (EBV) (14). EBV is an oncogenic virus that
causes multiple types of lymphomas and carcinomas (15–
17). EBV can transform resting primary B cells with very
high efficiency (18). This process requires co-expression of
the viral latent genes as well as of the BHRF1 miRNA
cluster that comprises three members (miR-BHRF1–1 to -
3). Cells immortalized with a mutant that lacks the miR-
BHRF1 cluster grow more slowly, show an abnormal
cell cycle distribution and undergo apoptosis more fre-
quently (19,20). Several cross-linking and immunoprecipi-
tation (CLIP) screens have identified potential cellular tar-
gets for the BHRF1 miRNAs (21–23), but which of these
genes represent the key targets of the BHRF1 miRNAs re-
mains to be determined. The EBV BART miRNA clus-
ter has also been suggested to contribute to transforma-
tion (24,25). Interestingly, the EBV miRNAs are mainly re-
quired at the beginning of the transformation process and
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infection of humanized mice with a mutant lacking the
BHRF1 miRNAs results in a tumor incidence similar to
wt-infected mice, although acute systemic EBV infection
is more pronounced in the presence of the BHRF1 cluster
(26). In the absence of the BHRF1 miRNAs, the transfor-
mation efficiency of the virus drops approximately 20 fold,
and this effect can be mainly ascribed to miR-BHRF1–2
and miR-BHRF1–3 (27). However, B cells infected with a
mutant virus that lacks miR-BHRF1–2 express markedly
reduced levels of miR-BHRF1–3, suggesting that wild type
expression of miR-BHRF1–3 requires miR-BHRF1–2.
In the present paper, we show that miR-BHRF1–3 alone
is processed with low efficiency and that miR-BHRF1–2’s
main contribution to the transformation process is to en-
hance miR-BHRF1–3 expression. Moreover, we investigate
the molecular mechanisms that control expression of miR-
BHRF1–3 and show that they are important to maintain
the transforming properties of the virus.
MATERIALS AND METHODS
Cell lines and cell culture
WI38 are human primary embryonic lung fibroblasts (28).
Raji is an EBV-positive cell line established from a Burkitt’s
lymphoma (29). HEK293 cells are derived from human em-
bryonic kidney cells by adenovirus transformation (30,31).
All cell lines were kept in RPMI 1640 medium (Gibco) sup-
plemented with 10% fetal bovine serum (FBS, Sigma). Pri-
mary human B cells were isolated by positive selection with
CD19 Dynabeads (Invitrogen) from buffy coats after den-
sity gradient centrifugation of whole blood on aFicoll cush-
ion. For generation of lymphoblastoid cell lines (LCLs), 5×
105 B cells were infected at a multiplicity of infection (MOI)
of five according to qPCR viral titers and subsequently kept
in RPMI 1640 with 10% FBS until outgrowth.
Construction of miRNA expression plasmids
All plasmids for miRNA analysis were cloned into the
mammalian expression vector pcDNA 3.1 (+). For a de-
scription of plasmid inserts and cloning methods, please re-
fer to Supplementary Experimental Procedures and Supple-
mentary Table S1.
Construction of EBV mutants
Recombinant viruses were cloned by chromosomal build-
ing or En passant mutagenesis of BAC DNA. For cloning
details, please refer to Supplementary Experimental Proce-
dures.
Generation of viral supernatants and viral titer determination
Viral BAC DNA was stably transfected into HEK293 cells
using Hygromycin B selection. Production of viruses was
triggered by transfection of BZLF1 and BALF4 expression
plasmids. Titers of obtained viral supernatants were deter-
mined by TaqMan qPCR or infection of Raji cells to deter-
mine the green Raji unit functional titer (gru). All steps are
described in detail in Supplementary Experimental Proce-
dures.
B cell transformation assay
To determine the efficacy of B cell transformation upon vi-
ral infection, primary B cells were infected at an MOI of
0.01 gru and seeded at a concentration of 102 cells per well
in 96-U wells, which were previously coated with 50Gy-
irradiated WI38 cells. At 31 days post infection (dpi), wells
with visible proliferation of B cells were counted as trans-
formed.
miRNA expression studies
For BHRF1 miRNA expression analysis, HEK293 cells
were seeded at a density of 2 × 105 cells per six-well and
transfected the following day with 1g plasmidDNAusing
Metafectene. 0.2g pEGFP-C1 was co-transfected per well
to normalize single experiments for differences in transfec-
tion efficiency. Medium was changed the next day, cells har-
vested 48 h after transfection, washed once in PBS and re-
suspended in 1ml PBS. 900 l of cell suspension were taken
for RNA extraction and 100l subjected to FACS analysis
of GFP-positive cells on a FACSCaliburTM flow cytome-
ter. To determine miRNA stability, transfected cells were
treated after changing medium with 5g/ml Actinomycin
D (Serva) for indicated times prior to harvesting.
RNA preparation
Total RNA from LCLs or transfected HEK293 cells was
extracted with TRIzol reagent (Ambion) according to the
manufacturer’s protocol. RNA pellets were dissolved in
50l H2O, concentration and purity determined on a Nan-
oDrop2000 spectrophotometer (Thermo Scientific) and all
samples adjusted to 400 ng/l for subsequent experiments.
In vitroRNA (IVR) transcriptionwas performedwith the
TranscriptAid T7 High Yield Transcription Kit (Thermo
Scientific) according to the manufacturer’s protocol with
corresponding pcDNA3.1 (+)-derived miRNA constructs
as a template, which were previously linearized at the 3′ end
with EcoRV. pcDNA3.1 (+) contains a T7 promoter. Se-
quences of in vitro transcripts are shown in Supplementary
Table S3. IVR samples were purified by Phenol-chloroform
extraction and RNA integrity monitored on 8% TBE acry-
lamide gels. Prior to each experiment, RNA was denatured
at 95◦C for 3 min, cooled down on ice for 3 min and folded
in 1× structure buffer (10 mM Tris–HCl, 80 mM KCl, 10
mMMgCl2, pH 7.0, supplemented with 400 u/ml RNAsin
(Promega)) at 37◦C for 30 min.
miRNA analysis by stem–loop RT-PCR
Quantification of miRNAs by stem–loop RT-PCR was de-
scribed previously (32). RT and stem–loop PCR primer se-
quences for BHRF1 miRNAs were as reported (33). Re-
verse transcription of all miRNAs was performed in one
reaction mix containing 12.5 nM of each RT primer with
the TaqMan MicroRNA Reverse Transcription Kit (Ap-
plied Biosystems) according to kit instructions. After re-
verse transcription, the concentration was adjusted to ob-
tain 2 ng/l template for stem–loop PCR. Each 20 l PCR
contained 10 l of 2× TaqMan Universal PCR Master
Mix (Applied Biosystems), 5 l of RT product, 1.5 M
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forward primer, 0.7 M universal reverse primer and 0.2
M probe. TaqMan MicroRNA RNU48 Assay (Applied
Biosystems) was used for normalization. Samples were in-
cubated at 95◦C for 10 min followed by 40 cycles of 95◦C
for 15 s and 56◦C for 1 min. For each miRNA, measure-
ments were performed in duplicates. Triplicate transfection
experiments were analyzed within one PCR plate, normal-
ized to one of three wt values according to Ct quan-
tification and corrected for differences in the percentage of
GFP-positive cells for HEK293 transfections. Unless spec-
ified otherwise, figures show average values of three experi-
ments with standard deviation (SD) error bars.
Microprocessor cleavage assay
To monitor cleavage of BHRF1 miRNA precursors, an in
vitro cleavage assay was performed. First, HEK293 cells
were transfected on a 100 mm cell culture plate with 8 g
Flag-Drosha and 2 g HA-DGCR8 expression plasmids
using Metafectene (Biontex). Medium was changed the fol-
lowing day. Cells were harvested 48 h post-transfection,
washed once with 5 ml ice-cold PBS and lysed in 300 l
ice-cold lysis buffer (20 mM Tris–HCl, 100 mM KCl, 200
M EDTA, 5% glycerol, 500 M DTT, 250 M PMSF,
pH 8.0). Flag-Drosha andHA-DGCR8were described pre-
viously (34). The Microprocessor lysate was sonicated five
times for 30 s intervals (Sonicator UW2070, Bandelin Elec-
tronic) and debris centrifugated at max speed for 10 min in
a tabletop centrifuge at 4◦C. For each cleavage reaction, a
mix in a total reaction volume of 30 l was prepared con-
taining 6.4mMMgCl2, 1 u/l RNAsin (Promega), 450fmol
of a folded IVR transcript encompassingmiR-BHRF1–2 or
-3 precursors or both (preparation as described above) and
15 l of Microprocessor lysate. Samples were incubated at
37◦C and snap-frozen at indicated time points on dry ice.
Controls containing lysate or RNAonly were added to each
assay. 50fmol of synthetic miR-BHRF1–2* or -3 was added
to RNA only controls of corresponding blots to be able to
adjust exposure time of corresponding miRNAs to differ-
ences in blot hybridization. Processed RNA was purified
after addition of 170 l elution buffer (300mM sodium ac-
etate, 2% SDS) by phenol-chloroform extraction. MiRNA
precursors were detected by Northern blotting as described
in Supplementary Experimental Procedures. Northern blot
probes and IVR sequences are listed in Supplementary Ta-
bles S2 and S3.
SHAPE analysis
We analyzed the RNA structure by ‘Selective 2′-hydroxyl
acylation analyzed by primer extension’ (SHAPE) as de-
scribed previously (35,36). For BHRF1 RNAmodification,
2pmol of folded RNA transcripts were mixed with 2 g
of yeast tRNA (Ambion) and incubated with 90 mM N-
methylisatoic anhydride (NMIA, Invitrogen) in 12 l total
volume for 40 min at 37◦C. Control reactions were treated
with anhydrous DMSO only. Reactions were stopped by
adding 88 l H2O and RNA purified by ethanol precipita-
tion. Pellets were dissolved in 7 l TE buffer (10 mM Tris–
HCl, 1 mM EDTA, pH 7.5).
Reverse transcription (RT) was performed as described
previously (37). A set of four primers (Life Technologies)
was used for RT reactions. A primer 5′ labeled with VIC
was chosen for modified samples or 5′ labeled with PET
for DMSO controls. Additionally, two sequencing reactions
were performed with unmodified RNA upon addition of
ddGTP or ddATP and a 6-FAM or NED 5′ labeled primer.
Primer binding sites were identical for all transcripts as
shown in Supplementary Table S3, where primer sequence
corresponds to 5′- TTATAGGCCTCACTGGCC -3′. All
four RT reactions were pooled, cDNA purified by phenol–
chloroform extraction and dissolved in 10 l deionized for-
mamide. Samples were processed by capillary electrophore-
sis on an ABI 3130xl Genetic Analyzer, capillary size 50
cm. ForRNA secondary structure prediction, electrophero-
grams were analyzed as described previously (38). SHAPE
reactivity values for each nucleotide were generated using
ShapeFinder 1.0 (39) and served as a basis for modeling of
secondary structures with RNAstructure 5.6 (40) using de-
fault values for the SHAPE slope (2.6 kcal/mol) and inter-
cept (−0.8 kcal/mol). Final structures were formatted with
XRNA 1.0.
Analysis software was downloaded from:
http://bioinfo.unc.edu/Downloads/index.html
http://rna.urmc.rochester.edu/rnastructure.html
http://rna.ucsc.deu/rnacenter/xrna/xrna download.html
RESULTS
MiR-BHRF1–2 and miR-BHRF1–3 are sequentially pro-
cessed from the same transcript
We previously observed a decrease in miR-BHRF1–3 ex-
pression in B cells infected with a virus that lacks pre-
miR-BHRF1–2 (27). We set out to determine the molec-
ular mechanisms that underlie the stimulating influence
of miR-BHRF1–2 on miR-BHRF1–3 expression by us-
ing expression plasmids on which either miR-BHRF1–2 or
miR-BHRF1–3 or both are cloned. We precisely quanti-
fied miRNA expression using stem–loop RT-PCR and in-
creasing amounts of synthetic miRNAs as standard curves.
This absolute quantification confirmed that a plasmid that
carries both miR-BHRF1–2 and miR-BHRF1–3 expressed
miR-BHRF1–3 at a much higher level than a plasmid that
carries miR-BHRF1–3 only (Figure 1A for normalized
quantification and Supplementary Figure S1A for abso-
lute values). This assay also revealed that expression plas-
mids on which the BHRF1 miRNAs are cloned express
them at levels that are close to the ones observed in EBV-
infectedLCLs (SupplementaryFigure S1A), althoughmiR-
BHRF1–3 levels are closer to those of miR-BHRF1–2 in
infected LCLs than they are in HEK293 cells transfected
with the expression plasmids. Quantitative miRNA North-
ern blots confirm these data (Supplementary Figure S1B).
We first assessed the stability of the BHRF1 miRNAs by
transfecting HEK293 cells with a plasmid that carries the
wild type (wt) BHRF1 locus in the presence of 5 g/ml
Actinomycin D. As expected, levels of BHRF1 transcripts
decreased over time. However, this assay did not reveal
any differences among any of the BHRF1 miRNAs (Sup-
plementary Figure S1C), as previously observed in LCLs
(41). Differences in expression levels of miR-BHRF1–3 can
therefore be taken as an indicator of changes in miRNA
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Figure 1. The processing of pre-miR-BHRF1–3 is driven by pre-miR-BHRF1–2. (A) Schematics of miRNA expression plasmids used in the study. miRNA
expression after transfection of these plasmids in HEK293 cells was quantified by stem–loop RT-PCR (Please see also Supplementary Figure S1). Results
show average values from triplicate transfection experiments ± standard deviation (SD). (B) Time course of a cleavage assay performed with in vitro
transcribed RNA carrying pre-miR-BHRF1–2 and -3 showing that pre-miR-BHRF1–2 accumulates more quickly than pre-miR-BHRF1–3 (Please see
also SupplementaryFigure S2). (C) This graph of bars shows the quantification of signals recorded in (B). Themean of the results from threeMicroprocessor
cleavage assays with pre-miR-BHRF1–2 and -3 is shown ± SD. The values are normalized using the signals generated by a spiked synthetic miRNA. (D)
Hybridization of an in vitro cleavage blot with a probe binding to a part of the 58nt long sequence between both miRNAs confirms their processing from
a single transcript. (E) The 58nt cleavage intermediate can also be detected in lymphoblastoid cell lines (LCLs) and transfected HEK293 cells indicating
that endogenous cleavage of both miRNAs also occurs from one transcript.
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processing efficiency, based on the assumption that the tran-
scription rate is identical in both plasmids.
The available data suggested that miR-BHRF1–2 is pro-
cessed before miR-BHRF1–3 in a 5′-3′ direction. We ex-
amined this hypothesis in more detail by performing Mi-
croprocessor cleavage assays for both miRNA precursors
using RNA transcribed in vitro from the miR-2–3 expres-
sion plasmid as template. We treated the in vitro transcribed
RNA with whole cell lysates of HEK293 cells transfected
with Drosha and DGCR8 expression plasmids and moni-
tored viral pre-miRNA cleavage over time using Northern
blotting. We used clearly defined amounts of spiked syn-
thetic miR-BHRF1–2 and -3 to allow precise quantifica-
tion of the cleaved pre-miRNAs and to allow normaliza-
tion between experiments. Indeed, the input RNA and high
molecular processing intermediates produced a smear upon
longer exposure that cannot be reliably quantified (Figure
1 and Supplementary Figure S1A). The analysis of three
independent experiments revealed that pre-miR-BHRF1–
2 was cleaved earlier and at a higher rate than pre-miR-
BHRF1–3 when encoded on the same plasmid (Figure 1B
and C). This confirms that a 5′-3′ directional processing
of the miRNAs takes place within the cluster (Supplemen-
tary Figure S2A). The analysis of pri-miR-BHRF1 process-
ing intermediates generated in these Microprocessor assays
added to this evidence; a longer exposure of the Northern
blot hybridized with a miR-BHRF1–3 probe revealed the
existence of slightly larger RNA fragments that carry un-
processed pre-miR-BHRF1–3 but were not visible on the
Northern blot hybridized with the miR-BHRF1–2 probe
(Supplementary Figure S2B).
Re-hybridization of the northern blot from Figure 1B
with a probe binding to the 58nt sequence located between
pre-miR-BHRF1–2 and -3 revealed a band of correspond-
ing size (Figure 1D), thereby confirming cleavage of both
precursors from the same transcript under in vitro condi-
tions. Furthermore, we could detect this 58nt fragment in
LCLs infected with EBV and in HEK293 cells transfected
with the wt BHRF1 miRNA expression plasmid, but not
in LCLs infected with a virus that lacks the BHRF1 miR-
NAs (Figure 1E). These data led us to the conclusion that
the BHRF1 miRNAs are generated from the same RNA
molecule in a 5′ to 3′ manner, with processing of miR-
BHRF1–2 preceding miR-BHRF1–3’s in vitro.
The miR-BHRF1–3 precursor displays a reduced propensity
to form a hairpin
The processing efficiency of a miRNA is strongly corre-
lated to its ability to properly form a hairpin structure (42).
Therefore, we used Selective 2′-Hydroxyl Acylation and
Primer Extension (SHAPE) (35,38) to precisely determine
the structure of the miR-BHRF1–2 and miR-BHRF1–3
stem–loops. Briefly, SHAPE takes advantage of differences
in the chemical reactivity of RNA nucleotides when they
are paired or unpaired. Unpaired nucleotides can be more
easily modified by N-methylisatoic anhydride (NMIA) that
binds to the free hydroxyl residue on the RNA sugar.
The NMIA-nucleotide complex builds a bulky adduct that
terminates reverse transcription. Therefore, the secondary
structure of a givenRNA can bemodeled from the obtained
extent of nucleotide modification along the transcript.
SHAPE analysis performed on in vitro transcribed RNA
revealed important differences between both miRNAs. The
energetically most favorable structures adopted by miR-
BHRF1–2 transcripts were pre-miRNA stem–loops with a
double-stranded hairpin (Figure 2A). In contrast, SHAPE
data for miR-BHRF1–3 showed that only a sub-fraction of
miR-BHRF1–3 transcripts formed a characteristic miRNA
stem–loop structure (Figure 2B) that corresponds to 29%
and 35% of all predicted miR-BHRF1–3 structures in two
independent experiments, in contrast to 92% and 100% for
miR-BHRF1–2 replicates (Table 1). The majority of the
predicted energetically favorable secondary structures of
miR-BHRF1–3 transcripts does not form a pre-miRNA
hairpin and is thus highly unlikely to recruit DGCR8 and
Drosha efficiently.
MiR-BHRF1–3’s intrinsic low expression is partially due to
co-transcriptional miRNA processing effects
Competition between transcription and pre-miRNA cleav-
age has previously been reported (43,44). MiRNAs that
are located close to the polyA site have less time available
for processing than miRNAs located at a more 5′ proxi-
mal site within the transcript. Therefore, we examined the
role played by the short distance between miR-BHRF1–3
and the transcript polyA cleavage site (272 bp) in HEK293
transfection experiments. A similar short distance is also
observed on the viral genome (201 bp). To this end, we
compared miR-BHRF1–3 expression from plasmids that
carry or do not contain the ‘AAUAAA’ polyA cleavage site
3′ of the BHRF1 miRNAs. Removing the polyA cleavage
site lengthens the size of the BHRF1 3′ UTR and could
potentially increase processing efficiency. This experiment
showed that increasing the distance between miR-BHRF1–
3 and the polyA site increased expression by 50% in the pres-
ence of miR-BHRF1–2 (Figure 3A). The effect was more
limited for miR-BHRF1–2 (15% increase). However, miR-
BHRF1–3 is located closer to the BHRF1 polyA site than
miR-BHRF1–2. This suggests that processing of BHRF1
miRNAs is coupled to transcription in our experimental
setting and is impaired by the short distance between miR-
BHRF1–3 and the polyA site, which might not allow timely
recognition of amiRNA stem–loopwithin the nascent tran-
script.
To further confirm our observations, we exchanged the
order of miR-BHRF1–2 and -3 stem–loops including their
respective flanking regions. This exchange indeed led to a
large decrease in miR-BHRF1–2 expression in transfected
HEK293 cells (Figure 3B). Expression of miR-BHRF1–3
also dropped when placed 5′ of miR-BHRF1–2. The most
likely explanation is that despite an increased distance to
the transcript end, recognition by the Microprocessor com-
plex is inefficient due to the low stem–loop stability of miR-
BHRF1–3 observed by SHAPE. MiR-BHRF1–3 process-
ing does not benefit from recruitment of the Microproces-
sor complex to the site of cleavage by the miR-BHRF1–2
stem–loop, when miR-BHRF1–2 is located 3′, confirming
that processing takes place in a 5′ to 3′ direction.
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A 
B 
miR-2_B9 Structure 1 miR-2_B9 Structure 2 
miR-2_B10 Structure 1 miR-2_B10 Structure 2 
miR-3_C9 Structure 1 miR-3_C9 Structure 2 
miR-3_C10 Structure 1 miR-3_C10 Structure 2 
miR-2 without SHAPE 
miR-3 without SHAPE 
0.4 >
0.85 >  0.4
 0.85
not determined
-134.7 kcal/mol -139.3 kcal/mol -139.1 kcal/mol
-163.7 kcal/mol -163.3 kcal/mol
-119.8 kcal/mol -119.4 kcal/mol
-108.0 kcal/mol -107.9 kcal/mol
-112.2 kcal/mol
Relative SHAPE reactivity 
Figure 2. SHAPE analysis of miR-BHRF1–2 and -3 stem–loop structure. The figure shows the two energetically most favorable structures of duplicate
SHAPE experiments performedwith a transcript encoding (A) pri-miR-BHRF1–2 or (B) pri-miR-BHRF1–3. The total folding free energy change,Gtotal,
is provided next to each folded structure.
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Table 1. Prevalence of structures containing a microRNA precursor from SHAPE-based analysis of BHRF1 transcripts
Transcript
Number of energetically most
favorable structures
Number of structures containing a
pre-miRNA % of ‘processable structures’
miR-2 B9 12 11 92%
miR-2 B10 13 13 100%
miR-3 C9 17 5 29%
miR-3 C10 17 6 35%
SHAPE analysis was performed in duplicates for both miRNAs and percentages were calculated by dividing the number of predicted structures showing
a miRNA precursor by the number of all energetically favorable structures.
Sequences surrounding the miRNA stem–loop contribute to
miR-BHRF1–3’s intrinsic low expression
We then attempted to link miR-BHRF1–3’s structural im-
perfections with a particular sequence. Previous work has
identified structural motifs essential for miRNA process-
ing. This includes the presence of flanking single-stranded
sequences 5′ and 3′ of a double-stranded 11nt base region
below the pre-miRNA hairpin (45,46). Particular sequence
motifs with an impact on pre-miRNA processing have also
been recently identified (47,48). They are located under-
neath the Drosha cleavage site and include a GC at posi-
tion −13, 5′ of the precursor, with the additional constraint
that the nucleotides should be base-paired. Additional mo-
tifs include a GNNU starting at position −3, and a CNNC
sequence 3′ of the precursor starting between position +16
to +18. An overview of structure and sequence elements
needed for efficient miRNA processing and their presence
or absence in BHRF1 pri-miRNAs is shown in Figure 4A.
We could observe a paired G at position −13 and the
presence of a CUAC sequence 3′ of pre-miR-BHRF1–2.
Although a 5′ GC was present before pre-miR-BHRF1–3
as well, the G was unpaired and no CNNC motif was de-
tected. We therefore exchanged the base of miR-BHRF1–2
and miR-BHRF1–3 to analyze the influence of these motifs
on BHRF1miRNAs. This led to a two-fold improvement in
miR-BHRF1–3 expression, while miR-BHRF1–2 levels re-
mained unchanged (Figure 4B). The absence of specific se-
quence elements might therefore contribute to the observed
low miR-BHRF1–3 expression, although the effect is mod-
erate.
We also confirmed that the reasons for inefficient expres-
sion of miR-BHRF1–3 are unlikely to be found within the
stem–loop structure itself bymutating different structure el-
ements inside the precursor.We investigated a potential role
played by the terminal loop ofmiR-BHRF1–3, since there is
increasing evidence for processing regulation through bind-
ing of regulatory proteins to terminal loop sequences (49),
and found that a mutant of miR-BHRF1–3 that carries the
miR-BHRF1–2 terminal loop is processed slightly better
than its unmodified version, but without reaching wt lev-
els (Supplementary Figure S3A). We also tried to improve
the formation of the hairpin by introducing mutations that
remove bulges or reinforcing base pairing but this did not
improve processing (Supplementary Figure S3B and S3C).
In a further step, we analyzed the influence of more dis-
tant surrounding sequences on pre-miR-BHRF1–3 process-
ing. To this end, we cloned the miR-BHRF1–2 and miR-
BHRF1–3 stem–loops flanked by unrelated prokaryotic se-
quences. This increased the expression of both miRNAs,
suggesting that the sequences around the BHRF1 gene are
generally not favorable for miRNA processing but never-
theless does not explain miR-BHRF1–3’s intrinsic weaker
production (Figure 4C).
The presence of an upstream miRNA is required for efficient
processing of miR-BHRF1–3 and efficient B cell transforma-
tion
Despite its structural flaws, miR-BHRF1–3 can reach good
expression levels, when it is encoded 3′ of miR-BHRF1–
2. We wondered whether another miRNA could repro-
duce this effect and exchanged the miR-BHRF1–2 precur-
sor with pre-hsa-miR-21 and monitored miRNA expres-
sion in HEK293 cells. This led to miR-BHRF1–3 expres-
sion at levels that did not differ from those observed with
miR-BHRF1–2 (Figure 5A). Thus, any efficiently processed
miRNA can assume the role played by miR-BHRF1–2 in
miR-BHRF1–3 expression. Expression was confirmed with
miRNA Northern blots for miR-BHRF1–3 and hsa-miR-
21 (Supplementary Figure S4A).
MiRNA processing leads to RNA breaks and we won-
dered whether this is what stimulates miR-BHRF1–3 ex-
pression. Therefore, we cloned a self-cleaving Hammerhead
Ribozyme (HHR) (50) 5′ of miR-BHRF1–3.We could con-
firm that this led to efficient autocatalytic RNA cleavage at
the expected HHR site (Supplementary Figure S4B). How-
ever, miR-BHRF1–3 located on the cleaved BHRF1 RNA
was not processed more efficiently than an intact counter-
part containing a cleavage-inactive ribozyme in transfected
HEK293 cells (Figure 5B). We therefore conclude that the
positive effect onmiR-BHRF1–3 expression results from ef-
ficient processing of an upstream miRNA and is probably
due to Microprocessor recruitment to the site of process-
ing. As a corollary, we concluded that this effect is probably
independent of the functionality of the upstream miRNA.
To confirm this hypothesis, we constructed a virus in
which both seed regions of miR-BHRF1–2 and miR-
BHRF1–2* were mutated to generate a double seed mu-
tant (miR2/2*DSM). The construction of this virus is de-
tailed in Supplementary Figure S5A. The mutant viral
DNA was stably transfected into HEK293 cells to gener-
ate HEK293/DSM producer cell lines from which infec-
tious viral stocks could be produced efficiently. LCLs gen-
erated with miR2/2*DSM expressed miR-BHRF1–1 and
miR-BHRF1–3 at normal levels (Figure 6A). The DSM
virus and a wt B95–8 control were used to perform transfor-
mation assays at low B cell density within a 96-well cluster
plate. No difference between wt and mutant was observed
in this assay at 31 days post infection (Figure 6B). Similarly,
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Figure 3. Processing of pre-miR-BHRF1–2 and -3 is linked with transcription. (A) To investigate whether Drosha-mediated processing of pre-miR-
BHRF1–2 and -3 is coupled to transcription, miRNA expression plasmids with deletion of the polyA cleavage signal (pA) were constructed. miRNA
expression changes in transfectedHEK293 cells were analyzed by stem–loopRT-PCR. (B) Transfection experiments with an expression plasmid containing
the same miRNAs but in reciprocal order were performed to confirm that close proximity to the polyA cleavage site is unfavorable as observed by the drop
in miR-BHRF1–2 expression. (A and B) Results show average values from triplicate transfections ± SD.
a BrdU incorporation assay did not reveal any difference
in terms of distribution within the cell cycle (Figure 6C).
We conclude that miR-BHRF1–2 or -2* do not influence
B cell transformation by target-seed interactions. Instead,
its main function in B cell transformation seems to be the
regulation of miR-BHRF1–3 expression. This represents a
hitherto not described function for a microRNA that goes
beyond the seed-mediated mRNA targeting.
Disruption of the sequence between miR-BHRF1–2 and -3
further increases miR-BHRF1–3 processing
The distance between pre-miR-BHRF1–2 and pre-miR-
BHRF1–3 is only 58nt. This could impose steric constraints
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Figure 4. Flanking sequences have an influence on miR-BHRF1–3 expression. (A) Schematic overview of the structural and sequence elements so far
recognized as necessary for efficient miRNA processing. The location of these nucleotides within the miR-BHRF1–2–3 transcript sequence is highlighted
in red; their absence is marked with an asterisk. (B) Hybrid miRNAs containing pre-miR-BHRF1–2 and miR-BHRF1–3’s base or pre-miR-BHRF1–2
and miR-BHRF1–3’s base were constructed. miRNA expression was measured by stem–loop RT-PCR after transfection of the plasmids into HEK293
cells. (C) Both miRNA stem–loops were cloned within a fragment of the -lactamase gene. miRNA expression was determined by stem–loop RT-PCR
after transfection of the plasmids into HEK293 cells. (B and C) Results show average values from triplicate transfections ± SD.
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Figure 5. A cellular miRNA can drive normal miR-BHRF1–3 expression. (A) Constructs containing pre-miR-BHRF1–2 and -3 or pre-hsa-miR-21 and
pre-miR-BHRF1–3 were transfected into HEK293 cells and BHRF1 miRNA levels were measured by stem–loop RT-PCR. (B) Similar experiments were
conducted with an auto-catalytically cleaving Hammerhead ribozyme (HHR) or a cleavage-deficient counterpart, which was inactivated through a point
mutation, placed 5′ of pre-miR-BHRF1–3. The results of the miRNA stem–loop RT-PCR after transfection of the plasmids in HEK293 are indicated (For
confirmation of HHR cleavage, please see Supplementary Figure S4). (A and B) Results show average values from triplicate transfections ± SD.
on expression of the miRNA located on the 3′ site of the
pair. As observed in SHAPE analysis and transfection ex-
periments, sequences surrounding pre-miR-BHRF1–3 neg-
atively influence processing of the miRNA through alterna-
tive folding of the transcript. We tested this hypothesis by
constructing plasmids in which the distance between both
miRNAs is increased through insertion of an 115nt spacer
sequence. Transfection assays showed that miR-BHRF1–
3 expression increases 1.5-fold with increased distance be-
tween both miRNAs (Figure 7A). A similar effect was vis-
ible with a plasmid that carries the same spacer, but in the
inverse orientation, and increasing the length of spacers led
to even higher miR-BHRF1–3 expression (Figure 7B).
Transfections with a plasmid, where a 115nt spacer se-
quence was inserted in front of miR-BHRF1–3 alone, also
result in an increase in miRNA levels, suggesting that dis-
ruption of the 5` flanking 58nt sequence contributes to an
improved miR-BHRF1–3 processing (Figure 7D). How-
ever, a plasmid in which the 58nt between miR-BHRF1–2
and -3 stem–loops is extensively mutated does not influence
miR-BHRF1–3 levels neither alone nor in presence of miR-
BHRF1–2 (Figure 7C and E).
Viruses with enhanced miR-BHRF1–3 expression become
less transforming
The results gathered so far suggest that miR-BHRF1–3 ex-
pression is boosted by the presence of miR-BHRF1–2, but
that the close proximity of both miRNAs and the sequence
between them actually limits this potentiating effect. This
suggests that miR-BHRF1–3’s expression needs to be care-
fully monitored. To test this hypothesis we constructed two
viruses in which the distance between bothmiRNAs was in-
creased by inserting spacer sequences that were either 115nt
or 207nt in length (EBV s115, EBV s207) (Supplementary
Figure S5B). The assumptionwas that this should lead to an
increase inmiR-BHRF1–3 expression and that we would be
able to test its consequences on B cell transformation. Fur-
thermore, we constructed a virus in which the 58nt region
between the two miRNAs was mutated (EBV m58). Be-
cause the external regions of the 58nt sequence are involved
in the processing of BHRF1–2 and -3, the mutagenesis was
limited to the 24 nucleotides located at the centre of this se-
quence (Supplementary Figure S5C). Primary B cells were
exposed to a set of viruses including both EBV s115 and
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Figure 6. MiR-BHRF1–2 and -2* have no direct impact on B cell transformation by EBV but regulate miR-BHRF1–3 levels. (A) miR-BHRF1 expression
was analyzed by stem–loop RT-PCR in LCLs generated with B95–8 or double seed mutant (DSM) EBV (please see also Supplementary Figure S5A for the
construction of the virus). (B) Transformation assays were performed by infection of primary B cells with 0.01 greenRaji units (gru) of B95–8 orDSMvirus.
Outgrowth of infected cells in 96-well plates was monitored and documented at 31 days post infection (dpi). (A and B) LCLs from four different donors
were analysed. Average values ± SD are shown. (C) A BrdU incorporation assay of B95–8 or DSM LCLs is shown with an example of the measurement
(left) and quantification from three experiments ± SD (right).
s207 spacer mutants, EBV m58, EBV 3 that lacks miR-
BHRF1–3, and a wild type B95–8 virus. Levels of BHRF1
miRNAs were assessed in LCLs obtained from three inde-
pendent blood samples (Figure 8A). We found that miR-
BHRF1–3 was not expressed in cells infected with EBV
3 as expected. In contrast, cells infected with the spacer
viruses expressed higher levels of miR-BHRF1–3 than cells
exposed to wild type viruses. However, spacer insertion did
not reduce expression of the anti-apoptotic BHRF1 protein
in LCLs generated by infection with s115 and s207, relative
to wt levels (Supplementary Figure S6). Cells infected with
EBVm58 displayed levels of miR-BHRF1–3 that were only
slightly lower than those observed in cells infected with the
wild type controls.
We first monitored cell growth at high cell density until 15
dpi and we found that infected B cells grew out more slowly
after infection with either of the spacer viruses, relative to
wild type controls (Figure 8B). As previously observed, B
cells infectedwith themiR-BHRF1–3 null mutant also grew
more slowly than the controls. In contrast, the same B cells
exposed to them58mutant displayed growth rates that were
indistinguishable from those of the B cells infected with the
wild type virus.
These results were largely confirmed by transformation
assays of B cells at a low cell density and low MOI in 96-
well cluster plates. We found that transformation with the
spacer viruses was approximately three times less efficient
than with the wt virus (Figure 8C) and that these viruses
achieved transformation rates that are close to those ob-
served with the miR-BHRF1–3 deletion mutant (27). How-
ever, this effect cannot be ascribed to a reduced expression
of the BHRF1 protein in the infected cells (Supplementary
Figure S6). We also find that the EBV m58 virus is glob-
ally endowed with the same transformation abilities as the
wild type virus, although the transformation rates varied be-
tween donors more markedly that with the other mutants.
Taken together with the results of experiments at high cell
density, these results indicate that the 58nt region has no
substantial influence on the transformation process.We also
conclude that a tight regulation of miR-BHRF1–3 expres-
sion is crucial for an efficient EBV-mediated B cell trans-
formation and that this fine-tuning is achieved through a
well-balanced coupling of miR-BHRF1–2 and -3 process-
ing within the BHRF1 miRNA cluster.
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Figure 7. Introduction of spacer sequences 5′ of miR-BHRF1–3 increases its expression. (A) A sequence of 115nt was cloned in both orientations be-
tween miR-BHRF1–2 and -3 onto an expression plasmid. The constructs were transfected into HEK293 cells to measure BHRF1 miRNA expression by
stem–loop RT-PCR. (B) The insertion of longer spacers measuring 207nt and 775nt in length between these miRNAs further increased miR-BHRF1–3
expression. (C) Partial shuffling of the 58nt intermediate sequence between pre-miR-BHRF1–2 and -3 does not influence miR-BHRF1–3 levels. (D and
E) Similar experiments were performed by changing the sequence 5′ of miR-BHRF1–3 in the absence of miR-BHRF1–2. (A and E) Results show average
values from triplicate transfections ± SD.
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Figure 8. Introduction of spacer sequences 5′ of miR-BHRF1–3 has a negative impact on EBV transforming abilities. (A) Expression of BHRF1 miRNAs
was measured by stem–loop RT-PCR in LCLs transformed with wild type or a set of mutant B95–8 recombinant viruses. These include two viruses
carrying 115nt (s115) and 207nt (s207) spacer inserts between miR-BHRF1–2 and miR-BHRF1–3, as well as a miR-BHRF1–3 knock-out mutant (3)
and a virus that carries a mutated 58nt sequence between miR-BHRF1–2 and miR-BHRF1–3 (m58) (please see also Supplementary Figure S5B and S5C
for construction of the viruses). LCLs from three different blood samples were included in the analysis whose results are given as average values ± SD.
(B) Shown are growth curves of B cells from two blood samples transformed by the same set of viruses at high cell density. (C) The same experiment was
repeated at low cell density and low multiplicity of infection in 96-well cluster plates. The average of the percentages of outgrown wells at 31 days post
infection (dpi) ± SD is indicated for four blood samples.
DISCUSSION
Most herpesviruses encode multiple miRNAs and these
have been shown to play key roles in viral infection such
as the control of virus lytic replication (51,52), apoptosis
of host cells (19,24,53) and the regulation of the immune
response against the virus (54). MiRNAs regulate EBV’s
defining feature, the ability of this virus to transform resting
B cells (19,20,24).
In the present paper, we focused on miR-BHRF1–3 and
its regulation. The expression of this miRNA is six times
higher within the cluster than when expressed on its own.
We identified two main molecular mechanisms responsi-
ble for its intrinsically low expression level. First, the prox-
imity of miR-BHRF1–3 to the polyA site of the BHRF1
transcript reduced its expression. This co-transcriptional ef-
fect results from a competition between transcription ter-
mination and the Microprocessor machinery and has pre-
viously been described for the cellular miRNAs let-7, lin-4
and hsa-miR-26 (43). Coupling of pre-miRNA processing
to transcription has also been shown for miRNAs located
in introns of protein-coding genes or within other tran-
scripts (43,44). Second, the miR-BHRF1–3 sequence itself
also accounts for its inefficient processing. Our data indi-
cate that motifs in the single-stranded RNA regions before
and after the stem–loop and in the terminal loop could play
some moderate role in this process. More importantly, the
SHAPE analysis (38) has clearly shown that a part of miR-
BHRF1–3 together with the RNA region located in the
58nt sequence directly 5′ of miR-BHRF1–3 build double-
stranded regions that are thermodynamically more favor-
able than the miRNA stem–loop. Intriguingly, according
to a publication by Altuvia et al. (55), 7 out of 31 human
small cluster regions containing two or more miRNA pre-
cursors are also separated by small 57–69nt intermediate se-
quences. This corresponds to one fifth (22.6%) of all clusters
described within the study and indicates that the short dis-
tance between miR-BHRF1–2 and miR-BHRF1–3 is not
unique (55). Human microRNA clusters with such a build-
up include clusters of oncogenic miRNAs such as miR-15b-
16–2 (59nt) and its paralogue miR-16–1–15a (57nt) cluster
or themiR-17∼92 cluster (35nt to 92nt).Whether themech-
anism of regulation we have identified in the miR-BHRF1
cluster extends to cellular miRNAs remains to be inves-
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tigated. More generally, there is an increasing recognition
that cellular miRNAs are also processed with variable effi-
ciency. This has been partially ascribed to the presence of
particular domains within the sequence that immediately
precedes the miRNA stem–loop (47,48), but our data in-
dicate that the global structure of the pre-miRNA and its
surrounding is likely to play a more important role in this
process.
The weak cleavage efficiency of miR-BHRF1–3 can be
corrected by preceding it with a cellular or a viral miRNA
but not by a ribozyme. This indicates that the potentiating
effect of miR-BHRF1–2 or hsa-miR-21 does not rest on a
mere cleavage of the pri-miRNA directly upstream of miR-
BHRF1–3, but rather requires another function mediated
by the miRNAs. The fact that miR-BHRF1–2 is processed
before miR-BHRF1–3 suggests that the first miRNA helps
recruiting the Microprocessor complex to the pri-miRNA
that can then sequentially processmiR-BHRF1–2 andmiR-
BHRF1–3. In this context, it is interesting to see that miR-
BHRF1–2 does not seem to play an important role through
its seed regions, as a virus that carries a miR-BHRF1–2
double seedmutant retains the wild type virus transforming
capacity. This does not mean that miR-BHRF1–2 mRNA
targets do not exist; they have been identified by CLIP tech-
niques, but simply that they do not influence EBV-mediated
transformation in vitro, one important but by far not unique
mode of virus-cell interaction. Thus, we have shown that
miRNAs can play a role that is independent of their seed
regions.
We have propounded a model in which miR-BHRF1–2
acts as a non-transformation-specific miRNA that allows
processing of a crucial mediator of transformation. Exami-
nation of miRNAs in EBV relatives in monkeys supports
this model. EBV belongs to the genus of Lymphocryp-
toviridae within the gammaherpesvirus subfamily, whose
members infect a very large number of animals, includ-
ing primates and many other mammals. A large number of
these viruses have been sequenced and the evolution of vi-
ral genes can be traced by sequence comparison. The rhesus
Lymphocryptovirus (rLCV) infects rhesus macaques and
the Cercopithecine herpesvirus 12 (CeHV12) primarily in-
fects Old World baboons. These viruses encode homologs
of the BHRF1 miRNAs that have been recently described
(23,49). Interestingly, the homology for pre-miR-BHRF1–2
between EBV, rLCV and CeHV12 is generally much higher
than for pre-miR-BHRF1–3, including the seed region (7/7
identical bases in the miR-BHRF1–2 seed region of the 3
viruses, and 7/7 or 6/7 for miR-BHRF1–2* versus 3/7 for
miR-BHRF1–3). Thus, we can anticipate that the homologs
of miR-BHRF1–2 will be efficiently processed and could
similarly facilitate processing of their downstreammiRNA.
One speculative scenario is that functional miR-BHRF1–
2 homologs, in that case miRNAs that are efficiently pro-
cessed, allowed the creation of polymorphic seed regions
across different organisms in miR-BHRF1–3, without hav-
ing to keep a structure that allows efficient processing, as
this is overtaken by the preceding miRNA thereby allow-
ing an efficient adjustment of target recognition in different
hosts. The length of the sequence between miR-BHRF1–2
and miR-BHRF1–3 is nearly identical in EBV and in these
monkey viruses, suggesting that this is an important feature
of these miRNAs that was conserved in both human and
primate viruses. The high susceptibility of miR-BHRF1–
3 expression to experimental mutagenesis of its sequence
might reflect the difficulty to achieve fine-tuned expression
in a range that is optimal for manipulation of pathways in-
volved in human B cell transformation.
Other modes of regulation of miRNA expression within
clusters have been described. For example, the oncogenic
miR-17∼92 cluster builds a large and complex structure
that brings some of the miRNAs in a peripheral position,
which facilitates their processing. In contrast, those miR-
NAs that are located inside the complex are more weakly
expressed, presumably because theMicroprocessormachin-
ery cannot efficiently access them (56,57). Furthermore,
binding of the hnRNP 1A cofactor selectively boosts the
expression of hsa-miR-18a within the cluster (58). Sub-
stantial differences in expression levels have also been re-
ported within the Kaposi’s Sarcoma-associated herpesvirus
(KSHV) K12 miRNA cluster. This was ascribed to differ-
ences in the structure and stability of the stem–loops that
could bemodulated bymodifying the sequence of the stem–
loop (37).
Why is miR-BHRF1–3 so tightly regulated? The advan-
tage of viral miRNAs is that they can be easily modified and
tested in the context of a complete organism. By construct-
ing viruses that contain a spacer between the BHRF1 miR-
NAs, we obtained miR-BHRF1–3 expression levels above
those recorded in cells infected with wild-type viruses (Fig-
ure 8A). Transformation experiments showed that an en-
hanced miR-BHRF1–3 expression decreased the efficiency
of transformation, both in bulk B cell infections and in in-
fections at limiting dilution. This suggests that too strong
a deregulation of miR-BHRF1–3´s targets impedes cell
growth. Combined to our previous observation that dele-
tion or strong reduction in miR-BHRF1–3 expression also
hampers transformation, this work provides an example of
a viral microRNA whose expression must be tightly con-
trolled to optimally serve its functions. Interestingly, some
of the targets that have been proposed for miR-BHRF1–3
include regulators of cell growth (21). There are indications
that a miRNA can regulate different subsets of target genes
depending on the miRNA concentration within a cell (59).
In the same study, it was shown that repression of a given
target mRNA does not linearly correlate with miRNA lev-
els, but has an optimum within a narrow range.
Taken together, our study provides an example of a vi-
ral miRNA whose expression must be kept within a speci-
fied range to optimally serve its functions. This is obtained
by including a weakly processed miRNA inside a cluster in
close proximity to a well-processed miRNA. The observa-
tions described in this study will not only improve our un-
derstanding of how viral miRNA expression is controlled
but might apply more generally to human miRNA clusters.
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